Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies
JACC: Basic to Translational Science
· Elsevier
Аннотация
Publication date: December 2026 Source: JACC: Basic to Translational Science, Volume 11, Issue 12 Author(s): Erin Morgan, Julia Weinland, Tao Lin, Gina McMullen, Jonathan H. Ward, Jani Saksi, Gail E. Geist, Carlos L. del Rio, Richard Geary, Adam Mullick, Sotirios Tsimikas
Читать у издателя →
Цитировать
Получайте новые статьи по теме «Кардиология и сердечно-сосудистая медицина»
Подписка, поиск по ключевым словам и избранное — в Telegram-боте Articlium.
Открыть в Telegram
Цитирование
✕
ГОСТ
APA
MLA
BibTeX
Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies. // JACC: Basic to Translational Science. – URL: https://www.sciencedirect.com/science/article/pii/S2452302X2600241X?dgcid=rss_sd_all
Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies. JACC: Basic to Translational Science. https://www.sciencedirect.com/science/article/pii/S2452302X2600241X?dgcid=rss_sd_all
“Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies.” JACC: Basic to Translational Science.
@article{article118862,
title = {Tonlamarsen, a Hepatocyte-Directed Antisense Oligonucleotide Targeting Angiotensinogen: Phase 1 and 2a Clinical Studies},
journal = {JACC: Basic to Translational Science},
url = {https://www.sciencedirect.com/science/article/pii/S2452302X2600241X?dgcid=rss_sd_all}
}